← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3176)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intratumoral para-toluenesulfonamide as a tumor-ablative therapy for equine cutaneous tumors: a case series of three horses. (2026/07/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Perioperative Immunonutrition in Patients Undergoing Lung Cancer Surgery: Current Evidence and Future Perspectives. (2026/07/21) ♡
- Prognostic value of nutritional and inflammatory biomarkers in patients with non-small cell lung cancer and bone metastasis: A retrospective study. (2026/07/21) ♡
- Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy. (2026/07/21) ♡
- Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer. (2026/07/20) ♡
- An integrated host vulnerability score is associated with survival in advanced NSCLC treated with nivolumab: a PET/CT-based real-world study. (2026/07/16) ♡
- Absolute risk of malignancy by treatment in patients with Crohn's disease compared to the general population: a nationwide population-based cohort study. (2026/07/16) ♡
- Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis. (2026/07/16) ♡
- Experimental investigation and network pharmacology-based analysis of the anticancer mechanisms of Fei Jin Sheng formula. (2026/07/16) ♡
- The application value of serous cavity effusion supernatant in multi-driver gene detection for non-small cell lung cancer. (2026/07/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial. (2026/07/15) ♡
- Clinical phenotype identification based on inflammation-nutrition-coagulation biomarkers in advanced non-small cell lung cancer. (2026/07/15) ♡
- The impact of sarcopenia on short-term efficacy, toxic and adverse reactions, and prognosis in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy. (2026/07/14) ♡
- Holistic oncologic management improves quality of life in driver gene negative advanced NSCLC a latent growth curve modeling study. (2026/07/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sing-a-Lung 2.0: protocol for a multicentre randomised controlled trial to investigate the effects and mechanisms of online-delivered singing training versus usual care 6-18 months after surgical resection for non-small cell lung cancer (NSCLC). (2026/07/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Triple-Component Lung Carcinoma Diagnosed After Nondiagnostic EBUS: A Case Report. (2026/07/10) ♡
- Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer. (2026/07/09) ♡
- Shuyu Wan Potentiates PD-1 Inhibitor Efficacy in Non-Small Cell Lung Cancer: Integrated Bioinformatics and Experimental Evidence for Gut Microbiota-Tumor Immune Crosstalk. (2026/07/08) ♡
- The Association and Predictive Value of Nutritional and Inflammatory Biomarkers in Advanced Non-Small Cell Lung Cancer Response to Immune Checkpoint Inhibitors. (2026/07/08) ♡
- Correction: EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells. (2026/07/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Marantic Endocarditis Presenting With Ischemic Stroke in Advanced Non-small Cell Lung Cancer: The Contribution of Fluorodeoxyglucose (FDG) PET/CT to the Differential Diagnosis of Valvular Vegetations. (2026/07/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Combination of polygonatum sibiricum and hedyotis diffusa induces pyroptosis in non-small cell lung cancer cells via the TLR4/NLRP3/Caspase-1/GSDMD pathway: an in vitro and in vivo study using medicated serum and herbal extract. (2026/07/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review. (2026/07/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Long-term efficacy of traditional Chinese medicine combined with chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of reconstructed individual patient data over 3 years. (2026/07/02) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Advances in radiotherapy-based multimodal treatment for non-small-cell lung cancer. (2026/07/02) ♡
- Gastrointestinal symptoms in Parkinson's disease treated in a controlled trial using traditional Chinese medicine (Jia-Wei-Ji-Chuan-Jian decoction) with network pharmacology analysis of active agents and mechanism of action. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review). (2026/07/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Insights from a randomized controlled trial on a digital lifestyle intervention in non-small cell lung cancer survivors following inpatient rehabilitation. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Therapeutic Strategies Targeting the KRAS G12C Mutation-Current Landscape and Future Directions]. (2026/07/01) ♡
- [Development of Therapies Targeting Non-G12C KRAS Mutations (Focusing on G12D and Pan-RAS)]. (2026/07/01) ♡
- [UPLC-Q-TOF-MS/MS-based guided isolation of phloroglucinols from Achyrocline satureioides and anti-lung cancer activity]. (2026/07/01) ♡
- Predictive Value of Peripheral Blood Inflammatory Markers and Nutritional Indices for Survival in Young Patients with Advanced Non-Small Cell Lung Cancer: Construction of a Nomogram. (2026/07/01) ♡
- Decoding Spectral Perturbations from a SERS Artificial Nose in Serum for Early Lung Cancer Detection. (2026/06/30) ♡
- Prognostic value of perioperative inflammatory biomarkers in patients undergoing surgical resection for non-small cell lung cancer. (2026/06/30) ♡
- A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction. (2026/06/29) ♡
- Deziyangxin suppresses non-small cell lung cancer through remodeling of the tumor immune microenvironment. (2026/06/28) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Heat-sensitive Moxibustion Enhances Immunity in Advanced Non-small Cell Lung Cancer via Th1/Th2 and Treg/Th17 Regulation. (2026/06/28) ♡
- Identification of unannotated microproteins involved in endothelial cell homeostasis, dysfunction, and vascular disease. (2026/06/26) ♡
- Body mass index and fasting insulin predict survival and EGFR-TKI benefit in Stage IV lung adenocarcinoma. (2026/06/25) ♡
- Prehabilitation in lung cancer patients undergoing lung resection surgery (Fit4LungNeo): study protocol. (2026/06/19) ♡
- Integrative Analysis of Glycosylation-Related Genes Reveals Prognostic Subtypes, Immune Evasion, and Therapeutic Vulnerabilities in Lung Adenocarcinoma. (2026/06/16) ♡
- Effect of hypoalbuminemia on postoperative pulmonary complications after thoracoscopic anatomical lung resection: a retrospective cohort study. (2026/06/11) ♡
- Variability of the prognostic nutritional index within 3 months after curative resection for non-small cell lung cancer and 2-year recurrence-free survival. (2026/06/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey. (2026/06/06) ♡
- Cost-Effectiveness Analysis of Anamorelin and Olanzapine for Cancer Cachexia in Non-Small Cell Lung Cancer Patients in Japan. (2026/06/04) ♡
- Comparison of PNI and GNRI nomogram models for predicting postoperative complications in elderly patients with lung cancer: a retrospective study. (2026/06/04) ♡
- Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC. (2026/06/03) ♡
- Zi Shen decoction inhibits non-small cell lung cancer progression by regulating macrophage polarization via the gut microbiota. (2026/06/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Submucosal-Predominant (Inverted-Type) Pyloric Gland Adenoma of the Duodenum Mimicking Malignancy. (2026/06/02) ♡
- Assessment of Circulating Cell Free DNA Methylation Biomarker of Panel of Selected Genes for Lung Cancer Detection. (2026/06/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.